30.05.23|Adrian Filut“There is a great significance to the physical presence of an innovation team within the hospital. It shows the staff, visitors and patients that innovation is at the core of our activity,” noted Dr. Eytan Wirtheim
21.05.23|Roni DoriAt 44, Gal Markel is a biotech bulldozer. After a $95 million exit, the professor of immunology serves as the Deputy Director General of Beilinson Hospital and the Director of the Davidoff Cancer Center, and is also involved in five startups. Now he has raised around $33 million to establish the Samueli Institute, researching ways to help the immune system eradicate cancer cells
14.10.21|CTechMichael Matias is joined by Leor Perl, chief innovation officer at Rabin Medical Center, to discuss building the bridge between medical needs and the world of entrepreneurship
More stories in CTech
